Introduction
Bioactive interleukin-12 p70 (IL-12p70) is a heterodimer composed of 2 subunits: p35 and p40. 1 Although p35 is expressed in numerous cell types, p40 expression is more restricted and determines the ability of a given cell-type to produce bioactive IL-12. 1 However, in the cells that are capable of producing both IL-12 subunits, it is the p35 subunit, produced in much lower amounts than p40, that plays the role of a limiting factor and determines the amount of bioactive IL-12p70 that is secreted. 1, 2 IL-12p70 heterodimer is a major Th1-driving cytokine. In contrast, p40 homodimer, secreted by antigen presenting cells (APCs) in the absence of p35 production, and to a lesser extent the p40 monomer, were shown to act as antagonists of mouse and human IL-12 receptors 1,3-5 and to inhibit IL-12-dependent immune functions in vitro and in vivo. [6] [7] [8] [9] [10] [11] [12] [13] Bioactive IL-12p70 is produced by dendritic cells (DCs) during their interaction with Th cells, as a result of CD40-CD40L interaction between these 2 cell types. [14] [15] [16] [17] [18] Although CD40-triggering alone provides a sufficient signal for the induction of IL-12p40 and several other cytokines, effective induction of IL-12p70 depends on the presence of an additional signal that can be provided by at least 2 of the Th cell-produced cytokines, interferon gamma (IFN␥) or IL-4. [17] [18] [19] DCs also produce both IL-12p40 and IL-12p70 in response to many microbial stimuli, including lipopolysaccharide (LPS) and Staphylococcus aureus Cowan strain I (SAC). 17, 18 Prostaglandin E 2 (PGE 2 ), is a common inflammatory mediator with a Th2-driving role at several levels of immune response. PGE 2 selectively impairs the production of IFN␥ and promotes the production of Th2 cytokines in murine and human Th clones, acting directly 20, 21 and by inhibiting the responsiveness to IL-12. 22 The presence of PGE 2 during the priming of naive Th cells, drives their development into Th2 subset. 23 At the level of APCs, PGE 2 inhibits IL-12p70 production in CD40L-or LPS-stimulated cells 24, 25 and can induce a stable IL-12-deficient, Th2-inducing phenotype in maturing DCs. 25, 26 A similar IL-12 antagonistic and Th2-promoting activity is shared by other and cyclic adenosine monophosphate (cAMP)-elevating agents, including ␤-adrenergic agonists, 27 histamine, 28 or cholera toxin. 29 In apparent contrast, PGE 2 was recently reported to synergize with tumor necrosis factor-alpha (TNF␣) in the induction of at least IL-12p40 subunit production in DCs, as determined by an IL-12p40-specific enzyme-linked immunosorbent assay (ELISA), sensitive for IL-12p70 heterodimer, p40 homodimer, and free p40 monomer. 30 This led to the proposal that at the inflammatory sites PGE 2 may paradoxically play the role of an IL-12 inducer, supporting cell-mediated immunity. Since PGE 2 is known to enhance the TNF␣-induced DC maturation, 26, 30, 31 its potential IL-12-inducing ability could be important for anticancer vaccination protocols utilizing DCs matured in the presence of a "complete cytokine mix," consisting of TNF␣, IL-1␤, IL-6, and PGE 2 . 31 Having in mind the opposite roles played by IL-12p70 and IL-12p40 and the different requirements for the induction of either factor in human DCs, 1, 2, [17] [18] [19] we tested whether the enhancement of IL-12p40 production in TNF␣-activated DCs by PGE 2 is accompanied by the induction of p35 gene transcription and by secretion of bioactive IL-12p70. Our results indicate that although PGE 2 participates in the induction of IL-12p40, this effect is selective and is not accompanied by the induction of p35 gene expression nor by the production of bioactive IL-12p70 heterodimer. In addition, PGE 2 suppresses the production of IL-12p70 induced by the "classical" inducers of cytokine production, LPS or CD40L.
Materials and methods
Generation of "tissue-type" immature CD1a ؉ CD83 ؊ DCs Monocytes were isolated from peripheral blood of healthy volunteers and cultured at 5 ϫ 10 5 cells/mL in Iscoves modified Dulbecco medium (IMDM) with 10% fetal calf serum (FCS) (Hyclone, Logan, UT) in the presence of rhu granulocyte-macrophage-colony-stimulating factor (GM-CSF) (500 U/mL; a gift of Schering-Plough, Uden, The Netherlands) and rhuIL-4 (250 U/mL; Strathman, Hannover, Germany) for 6 days, as described elsewhere. 25, 26 At day 6, the cultures consisted of uniformly HLA-DR ϩ (L243; Becton Dickinson, San Jose, CA), CD83 Ϫ (HB15; Immunotech, Marseille, France) immature DCs, without detectable CD3 ϩ cells, as analyzed by FACScan (Becton Dickinson). Over 90% of the cells expressed high levels of CD1a (OKT6; Ortho, Beerse, Belgium).
Analysis of cytokine production
At day 6, DCs were washed, counted, and stimulated (4 ϫ 10 4 ) in a final volume of 200 mL by rhuTNF␣ (50 ng/mL, corresponding to 5 ϫ 10 3 U/mL, Pharma Biotechnologie Hannover), LPS (250 ng/mL, Difco, Detroit, MI), or CD40L-transfected J558 plasmacytoma cells (J558-CD40L, 5 ϫ 10 4 cells per well) (a gift of Dr P. Lane, Birmingham, United Kingdom), which were previously shown to induce IL-12 p70 in an IFN␥-independent way, 16 alone or in combination with PGE 2 (10 Ϫ5 M -10 Ϫ9 M, as indicated; Sigma, St Louis, MO), or rhuIFN␥ (1000 U/mL; a gift of Dr P. H. van der Meide, U-CyTech, Utrecht, The Netherlands), as indicated, for an additional period of 48 hours. The concentrations of cytokines in 48-hour supernatants were analyzed with specific solid phase sandwich ELISAs.
Cytokine measurements
IL-12p70 ELISA (sensitivity, 3 pg/mL), 27 was performed with use of p70-specific mAb 20C2 (a gift from Dr M.K. Gately, Hoffmann-La Roche, Nutley, NJ) and p40-specific C8.6 mAb (a gift from Dr G. Trinchieri, The Wistar Institute, Philadelphia, PA). IL-12p40-specific ELISAs, recognizing p40 monomer, p40 homodimer, and p70 (p40 ϩ p35) heterodimer were performed as described elsewhere. 2, 25 Analysis of p35 and p40 mRNA expression DCs (3 ϫ 10 5 cells in 2 mL) were stimulated with the combination of TNF␣ (50 ng/mL) and PGE 2 (10 Ϫ6 M) in the presence of IFN␥ (1000 U/mL) or with LPS (250 ng/mL) and IFN␥ (1000 U/mL), as indicated. Unstimulated DCs and DCs exposed to IFN␥ alone were used as negative controls. Cells were lyzed after 6 hours and total RNA was isolated using the RNeasy Kit (Qiagen, Hilden, Germany). First-strand cDNA was synthesized from the total amount of RNA using Moloney murine leukemia virus (mMLV)-derived reverse transcriptase (RT) (MBI fermentas, Vilnius, Lithuania). Polymerase chain reaction (PCR) amplification of p35 (3:l of cDNA; 40 cycles) and p40 (2:l of cDNA; 35 cycles) was carried out using the p35 and p40 primers, 2 resulting in the products of 533 base pair (bp) and 267 bp, respectively. PCR specific for human b2m (1:l cDNA, 35 cycles) was performed with specific primers, 32 resulting in the product of 286 bp. Ethidium bromide-stained PCR products were analyzed on agarose gel by Eagle-Eye (Stratagene, La Jolla, CA) and SigmaGel software (SPSS Science, Jandel Scientific Software, Chicago, IL).
Results
The induction of IL-12p40 mRNA and protein in DCs by TNF␣ and PGE 2 is selective and is not accompanied by the induction of IL-12p35 mRNA or bioactive IL-12p70 heterodimer PGE 2 was previously shown to enhance the TNF␣-induced final maturation of DCs, 26, 30, 31 which was accompanied by the production of at least a p40 subunit of IL-12. 30 To test whether the production of p40 in these conditions is accompanied by the induction of an IL-12p35 subunit and the secretion of bioactive IL-12p70, we analyzed the regulation of both IL-12 forms in TNF␣-activated DCs by PGE 2 .
In accordance with the previous report, immature DCs exposed to TNF␣ (50 ng/mL) produced low, but clearly detectable, amounts of IL-12p40, found in 48-hour supernatants ( Figure 1A,B) . Addition of increasing concentrations of PGE 2 to the cultures of TNF␣-stimulated DCs dose-dependently enhanced the IL-12p40 production. At all concentrations, the IL-12p40 induction was selective and was not accompanied by the induction of IL-12p70 heterodimer ( Figure 1A ). Although the combination of TNF␣ and PGE 2 was as effective as LPS (250 ng/mL) in the induction of IL-12p40 production, exclusively LPS, but neither TNF␣ alone nor the combination of TNF␣ and PGE 2 , could induce IL-12p70 production ( Figure 1B) .
Previously, we have shown that the physiologic levels of CD40 triggering, by CD40L-expressing Th cells, for example, are sufficient to induce IL-12p40 production, but the efficient induction of IL-12p70 requires an additional IFN␥-mediated or IL-4-mediated signal. [18] [19] [20] Similarly, IFN␥ strongly enhances the IL-12p70 (and to a lesser extent IL-12p40) production in immature DCs and monocytes stimulated by bacterial products. 2, 18, 19, 25 Therefore, we tested if the selective inability of TNF␣ and PGE 2 to induce IL-12p70 production can be overcome by IFN␥. As expected, 2,18-20 IFN␥ (1000 U/mL) strongly enhanced the IL-12p70 (and IL12p40) production by LPS-stimulated DCs ( Figure 1B ). In contrast, the addition of IFN␥ to DC cultures stimulated either with TNF␣ alone or with the combination of TNF␣ and PGE 2 , did not induce any detectable IL-12p70 production and suppressed the production of IL-12p40 ( Figure 1B) .
Since the secretion of bioactive IL-12p70 requires the production of both IL-12 subunits, p35 and p40, we analyzed the induction of mRNA encoding either of these subunits. As shown in Figure 2 , both p35 and p40 expression were observed in DCs stimulated with LPS and IFN␥. In contrast, stimulation with TNF␣/PGE 2 and IFN␥ resulted with the selective induction of p40 in the absence of p35 induction. These results indicate that, even in the presence of IFN␥, a powerful coinducer of IL-12 production, the combination of inflammatory factors TNF␣ and PGE 2 does not induce the bioactive IL-12p70.
PGE 2 inhibits the production of both forms of IL-12 in DCs stimulated with the "classical IL-12 inducers" CD40L or LPS
To test whether PGE 2 differentially regulates the production of IL-12p40 and IL-12p70, also during the stimulation of DCs with other stimuli, we added increasing concentrations of PGE 2 to DC cultures stimulated with 2 classical IL-12 inducers known to induce both IL-12p40 and bioactive IL-12p70-LPS and CD40L-transfected J558 cells (J558-CD40L) that express very high levels of CD40L. As shown in Figure 3 , PGE 2 inhibited the production of both IL-12p70 and IL-12p40 production induced by either of these stimuli.
Discussion
The current demonstration that the PGE 2 -assisted enhancement of IL-12p40 production in TNF␣-stimulated DCs is selective and not accompanied by the induction of bioactive IL-12p70 heterodimer allows to resolve the current controversy concerning the role of PGE 2 in IL-12 regulation and confirms the role of PGE 2 as a factor with a multiple Th2-driving activities. PGE 2 is known to exert Th2-promoting and IL-12-antagonistic activity via several distinct mechanisms, affecting both APCs and Th cells. It suppresses the production of bioactive IL-12p70, both directly [24] [25] [26] and by inhibiting the Th-cell production of IFN␥, 20, 21 an important coinducer of IL-12 during DC-Th cell cocultures. [17] [18] [19] PGE 2 also inhibits the responsiveness of T cells to IL-12 by downregulating the expression of the IL-12 receptor. 22 Another example of IL-12-antagonistic and Th2-driving function of PGE 2 is the induction of IL-10. PGE 2 is known to enhance IL-10 production in mouse and human monocytes or in DC, when present at early stages of their development. 25, [35] [36] [37] [38] [39] [40] However, in the current experiments, PGE 2 did not enhance IL-10 production during the TNF␣-or LPS-induced DC maturation, and it did not prime maturing DC for elevated IL-10 production upon subsequent CD40L stimulation (data not shown).
Human DCs matured in the presence of PGE 2 showed reduced IL-12-producing capacity, compared with mature DCs obtained in the presence of high doses of IL-1␤ and TNF␣ alone, and preferentially induce Th2 cytokines in naive Th cells. 26 The observation that such IL-12-deficient and control DCs showed the same expression of maturation-associated markers, 26 together with the currently reported ability of PGE 2 to directly inhibit the IL-12 production in LPS-or CD40L-activated DCs (Figure 3) , argue that the IL-12 suppressive activity of PGE 2 does not merely reflect its ability to accelerate DC maturation (a process associated with a decrease in IL-12 production 33, 34 ), but represents a specific IL-12 inhibitory function.
The presently described selective induction of IL-12p40 suggests the existence of an additional level of Th2-promoting and IL-12-antagonistic activity of PGE 2 , mediated by p40 homodimer, or by free IL-12p40. Both in mouse and in human systems, it was demonstrated that p40 homodimer and to a lesser extent also the product of its dissociation, free p40 monomer, can suppress the responsiveness to IL-12 by competitively inhibiting the IL-12 receptor binding. 1, [3] [4] [5] This activity is very well pronounced in mice where p40 homodimer exerts the antagonistic activity with an IC 50 of 1-10 ng/mL, whereas in humans concentrations at least 10-fold higher are required. [3] [4] [5] Mouse p40 homodimer was shown to effectively antagonize IL-12 activity in vivo, as a factor rescuing the animals from lethal LPS-induced shock and suppressing the Th1-dominated inflammatory responses in several models of chronic inflamation, transplantation, and cancer. [6] [7] [8] [9] [10] [11] [12] In humans, high levels of IL-12p40 in peritoneal fluid were postulated to play an IL-12-antagonistic role in endometriosis, as a factor locally inhibiting the activity of natural killer (NK) cells. 13 Unfortunately, poor stability of human p40 homodimer 1 constitutes a serious obstacle in analyzing its physiologic role, and its potential therapeutic in vivo use in transplantation and autoimmune diseases. For the same reason, we could not determine if the PGE 2 -induced IL-12p40 was released from DCs as p40 homodimer or as p40 monomer, a less potent IL-12 antagonist. 1 Current demonstration of the selective induction of inactive/ antagonistic IL-12p40 argues against the proposed Th1-promoting role for PGE 2 at the inflammatory sites. 30 On the contrary, selective induction of IL-12p40 by PGE 2 is likely to contribute to selective suppression of Th1-type responses in chronic inflammation, and may play a role in the immune deviation induced by the PGE 2 -producing tumors. [35] [36] [37] [38] [39] [40] Although PGE 2 enhances the expression of costimulatory molecules on DCs and increases their ability to stimulate CD4 ϩ and CD8 ϩ T cells, 26, 30, 31 the ability of PGE 2 to induce IL-12p40 production and to suppress the IL-12p70-producing ability of DCs 25, 26 may impair the tumoricidal functions of Th1, NK cells, and cytotoxic T lymphocytes. Multiple levels of IL-12 antagonism of PGE 2 may have a negative impact on the effectiveness of immunotherapeutic protocols that use PGE 2 in combination with IL-1␤, TNF␣, and IL-6 to induce mature DCs for anticancer vaccination. 31 It remains to be tested whether the benefit of an enhanced stimulatory capacity of PGE 2 -matured DCs is sufficient to offset the IL-12 antagonistic effects of PGE 2 .
